New insights in the TRAZELGA project for the adult type 1 Gaucher disease patients treated with eliglustat follow-up
Idioma: Inglés
DOI: 10.1016/j.ymgme.2020.12.239
Año: 2021
Publicado en: Molecular genetics and metabolism 132, 2 (2021), S99-S99
ISSN: 1096-7192

Factor impacto JCR: 4.204 (2021)
Categ. JCR: ENDOCRINOLOGY & METABOLISM rank: 69 / 147 = 0.469 (2021) - Q2 - T2
Categ. JCR: GENETICS & HEREDITY rank: 67 / 177 = 0.379 (2021) - Q2 - T2
Categ. JCR: MEDICINE, RESEARCH & EXPERIMENTAL rank: 70 / 140 = 0.5 (2021) - Q2 - T2

Factor impacto CITESCORE: 7.1 - Medicine (Q1) - Biochemistry, Genetics and Molecular Biology (Q2)

Factor impacto SCIMAGO: 1.011 - Biochemistry (Q1) - Molecular Biology (Q1) - Genetics (Q1) - Endocrinology, Diabetes and Metabolism (Q1)

Tipo y forma: Congress (Published version)

Creative Commons You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.


Exportado de SIDERAL (2023-05-18-14:21:55)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
Articles



 Record created 2021-05-07, last modified 2023-05-19


Versión publicada:
 PDF
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)